Gene therapy trial hopes to tame rare brain disorder

NCT ID NCT07135050

First seen Jan 09, 2026 · Last updated Apr 30, 2026 · Updated 22 times

Summary

This early-stage trial tests a one-time gene therapy called MZ-1866 for children and adults with Pitt Hopkins Syndrome, a rare genetic condition affecting development. The study will enroll 12 participants to check if the treatment is safe and tolerable. Researchers will monitor side effects and use developmental assessments to see how participants respond.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for PITT HOPKINS SYNDROME are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Children's Hospital Colorado

    RECRUITING

    Aurora, Colorado, 80045, United States

    Contact

    Contact Phone: •••-•••-•••• Email: •••••@•••••

  • Rush University Medical Center

    NOT_YET_RECRUITING

    Chicago, Illinois, 60612, United States

    Contact

    Contact Email: •••••@•••••

  • UCSF Benioff Children's Hospital Oakland

    RECRUITING

    Oakland, California, 94609, United States

    Contact

    Contact Email: •••••@•••••

Conditions

Explore the condition pages connected to this study.